- Home
- AUPH vs INDV Comparison
AUPH vs INDV Comparison
Compare AUPH & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- INDV
- Stock Information
- Founded
- AUPH 1993
- INDV 1994
- Country
- AUPH Canada
- INDV United States
- Employees
- AUPH N/A
- INDV 1164
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- INDV Biotechnology: Pharmaceutical Preparations
- Sector
- AUPH Health Care
- INDV Health Care
- Exchange
- AUPH Nasdaq
- INDV Nasdaq
- Market Cap
- AUPH 1.1B
- INDV 1.4B
- IPO Year
- AUPH 1999
- INDV N/A
- Fundamental
- Price
- AUPH $8.01
- INDV $11.56
- Analyst Decision
- AUPH Strong Buy
- INDV Strong Buy
- Analyst Count
- AUPH 3
- INDV 2
- Target Price
- AUPH $10.33
- INDV $16.00
- AVG Volume (30 Days)
- AUPH 1.3M
- INDV 1.1M
- Earning Date
- AUPH 02-13-2025
- INDV 02-20-2025
- Dividend Yield
- AUPH N/A
- INDV N/A
- EPS Growth
- AUPH N/A
- INDV N/A
- EPS
- AUPH N/A
- INDV N/A
- Revenue
- AUPH $220,361,000.00
- INDV $1,182,000,000.00
- Revenue This Year
- AUPH $36.97
- INDV $6.13
- Revenue Next Year
- AUPH $16.43
- INDV N/A
- P/E Ratio
- AUPH N/A
- INDV N/A
- Revenue Growth
- AUPH 38.72
- INDV 13.44
- 52 Week Low
- AUPH $4.71
- INDV $7.33
- 52 Week High
- AUPH $10.67
- INDV $23.22
- Technical
- Relative Strength Index (RSI)
- AUPH 45.28
- INDV 47.19
- Support Level
- AUPH $7.67
- INDV $11.90
- Resistance Level
- AUPH $8.54
- INDV $12.39
- Average True Range (ATR)
- AUPH 0.27
- INDV 0.31
- MACD
- AUPH 0.03
- INDV -0.04
- Stochastic Oscillator
- AUPH 43.62
- INDV 48.53
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing LUPKYNIS (voclosporin), an investigational drug, for the treatment of lupus nephritis (LN), and others. Geographically, it derives maximum revenue from the United States.
About INDV Indivior PLC
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.